SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARZOLA, Giuliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.681
AS - Asia 1.241
EU - Europa 974
SA - Sud America 154
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 5
Totale 5.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.616
SG - Singapore 440
CN - Cina 359
DE - Germania 334
FI - Finlandia 165
VN - Vietnam 148
BR - Brasile 118
IT - Italia 108
UA - Ucraina 105
GB - Regno Unito 99
HK - Hong Kong 68
TR - Turchia 62
BD - Bangladesh 47
FR - Francia 46
CA - Canada 41
SE - Svezia 36
IN - India 27
JP - Giappone 22
RU - Federazione Russa 20
MX - Messico 15
PL - Polonia 13
IQ - Iraq 10
ES - Italia 9
LT - Lituania 9
NL - Olanda 9
PK - Pakistan 9
UZ - Uzbekistan 9
AR - Argentina 8
ID - Indonesia 8
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
AU - Australia 5
EG - Egitto 5
IL - Israele 5
PY - Paraguay 5
CO - Colombia 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
BE - Belgio 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BY - Bielorussia 1
EE - Estonia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MQ - Martinica 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.083
Salva come PNG Salva come JPEG
Città #
Ashburn 341
Singapore 276
Munich 250
Fairfield 226
Woodbridge 214
Houston 173
San Jose 143
Beijing 124
Jacksonville 117
Helsinki 108
Santa Clara 97
Chandler 95
Ann Arbor 94
Seattle 88
Wilmington 84
Cambridge 78
Hong Kong 66
New York 66
Dallas 62
Ho Chi Minh City 49
Los Angeles 45
Council Bluffs 42
Nanjing 34
Hanoi 31
Izmir 29
Shanghai 28
San Diego 26
Turku 26
Boardman 25
Milan 24
Princeton 24
Orem 22
Tokyo 21
Frankfurt am Main 18
São Paulo 18
Lauterbourg 17
Ferrara 16
The Dalles 16
London 13
Mcallen 13
Buffalo 12
Montréal 12
Bremen 11
Chennai 11
Denver 11
Montreal 11
Chicago 10
Haiphong 10
Mexico City 10
Toronto 10
Atlanta 9
Dearborn 9
Poplar 9
Rome 9
Stockholm 9
Tianjin 9
Guangzhou 8
Hebei 8
Nanchang 8
Shenyang 8
Tashkent 8
Warsaw 8
Brooklyn 7
Da Nang 7
Falkenstein 7
Hefei 7
Manchester 7
Amsterdam 6
Dhaka 6
Falls Church 6
Jyväskylä 6
Washington 6
Addison 5
Baghdad 5
Bexley 5
Bologna 5
Changsha 5
Johannesburg 5
Mountain View 5
Norwalk 5
Philadelphia 5
Rio de Janeiro 5
San Mateo 5
Sydney 5
Tappahannock 5
Indiana 4
Jiaxing 4
Naples 4
Newark 4
Phoenix 4
San Francisco 4
Ardabil 3
Asunción 3
Auburn Hills 3
Barnet 3
Boston 3
Brasília 3
Brussels 3
Bến Tre 3
Caracas 3
Totale 3.630
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 411
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 323
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 279
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 274
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 269
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 267
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 259
Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists 259
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 257
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 237
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 233
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 230
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 230
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 221
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 208
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 204
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 203
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 199
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 198
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 173
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 120
null 50
Totale 5.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 31 33 17 18 13 12 20 9 26 25 71
2022/2023232 21 18 21 31 37 26 17 14 27 1 9 10
2023/2024183 14 15 11 7 9 58 8 13 4 1 8 35
2024/2025901 7 14 44 39 74 119 106 80 167 46 97 108
2025/20261.865 203 67 143 264 258 130 209 91 175 177 123 25
2026/2027100 50 50 0 0 0 0 0 0 0 0 0 0
Totale 5.104